Emmaus Life Sciences (EMMA) Change in Accured Expenses (2010 - 2026)
Emmaus Life Sciences (EMMA) recorded Change in Accured Expenses of -$1.01 million in Q2 2026, compared with $1.11 million a year earlier.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) Change in Accured Expenses (2010 - 2026) Analysis & Trends
On a TTM basis, Emmaus Life Sciences' Change in Accured Expenses came in at $4.86 million as of Jun 30, 2026, up 216.6% year-over-year; for FY2025, it came in at $6.46 million, up 396.6% from FY2024.
- Across earlier years, Change in Accured Expenses came in at $1.3 million in FY2024 (-72.9%), $4.8 million in FY2023 (+30.5%), $3.68 million in FY2022 (+78.5%) and $2.06 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Change in Accured Expenses since Q1 2021.
- Peak year-over-year performance for Change in Accured Expenses in the last five years was growth of 88.9% in Q1 2023, against a decline of 56.8% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.87 million (Q1 2026), $1.58 million (Q4 2025) and $2.41 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,124.12 Bn | 1,092.71 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 634.38 Bn | 554.24 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 505.39 Bn | 478.50 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 357.36 Bn | 311.74 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 290.21 Bn | 254.20 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.21 Bn | 238.89 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.81 Bn | 193.21 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn | -1.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.01 Mn |
| Mar 31, 2026 | 1.87 Mn |
| Dec 31, 2025 | 1.58 Mn |
| Sep 30, 2025 | 2.41 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 1.35 Mn |
| Dec 31, 2024 | -593,000.00 |
| Sep 30, 2024 | -336,000.00 |
| Jun 30, 2024 | 757,000.00 |
| Mar 31, 2024 | 1.47 Mn |
| Dec 31, 2023 | 2.33 Mn |
| Sep 30, 2023 | 266,000.00 |
| Jun 30, 2023 | 1.20 Mn |
| Mar 31, 2023 | 1.00 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 307,000.00 |
| Jun 30, 2022 | 642,000.00 |
| Mar 31, 2022 | 530,000.00 |
| Dec 31, 2021 | 2.23 Mn |
| Sep 30, 2021 | 711,000.00 |
API Access
Emmaus Life Sciences Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();